These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24932711)

  • 1. Mechanism of 2-hydropropyl-beta-cyclodextrin in the stabilization of frozen formulations.
    Wong J; Kipp JE; Miller RL; Nair LM; Ray GJ
    Eur J Pharm Sci; 2014 Oct; 62():281-92. PubMed ID: 24932711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excipients for Room Temperature Stable Freeze-Dried Monoclonal Antibody Formulations.
    Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
    J Pharm Sci; 2020 Jan; 109(1):807-817. PubMed ID: 31622600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of meropenem in normal saline solution after storage at room temperature.
    Jaruratanasirikul S; Sriwiriyajan S
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):627-9. PubMed ID: 15115140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cations and anions on glass transition temperatures in excipient solutions.
    Nesarikar VV; Nassar MN
    Pharm Dev Technol; 2007; 12(3):259-64. PubMed ID: 17613889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using dextran of different molecular weights to achieve faster freeze-drying and improved storage stability of lactate dehydrogenase.
    Larsen BS; Skytte J; Svagan AJ; Meng-Lund H; Grohganz H; Löbmann K
    Pharm Dev Technol; 2019 Mar; 24(3):323-328. PubMed ID: 29781745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Cyclodextrin complexation as an effective drug delivery system for meropenem.
    Paczkowska M; Mizera M; Szymanowska-Powałowska D; Lewandowska K; Błaszczak W; Gościańska J; Pietrzak R; Cielecka-Piontek J
    Eur J Pharm Biopharm; 2016 Feb; 99():24-34. PubMed ID: 26592156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures.
    Franceschi L; Cojutti P; Baraldo M; Pea F
    Ther Drug Monit; 2014 Oct; 36(5):674-6. PubMed ID: 24637698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of supramolecular interactions of dextran-β-cyclodextrin polymers on invertase activity in freeze-dried systems.
    Santagapita PR; Mazzobre MF; Buera MP; Ramirez HL; Brizuela LG; Corti HR; Villalonga R
    Biotechnol Prog; 2015; 31(3):791-8. PubMed ID: 25736897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a lyophilised RH1 formulation: a novel DT diaphorase activated alkylating agent.
    Elliott MA; Ford SJ; Walker AA; Hargreaves RH; Halbert GW
    J Pharm Pharmacol; 2002 Apr; 54(4):487-92. PubMed ID: 11999125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mAb and excipient cryoconcentration on long-term frozen storage stability - Part 1: Higher molecular weight species and subvisible particle formation.
    Bluemel O; Anuschek M; Buecheler JW; Hoelzl G; Bechtold-Peters K; Friess W
    Int J Pharm X; 2022 Dec; 4():100108. PubMed ID: 35024603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal and alkaline stability of meropenem: degradation products and cytotoxicity.
    Mendez A; Chagastelles P; Palma E; Nardi N; Schapoval E
    Int J Pharm; 2008 Feb; 350(1-2):95-102. PubMed ID: 17904314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glass transitions in frozen systems as influenced by molecular weight of food components.
    Zhao JH; Kumar PK; Sablani SS
    Compr Rev Food Sci Food Saf; 2022 Nov; 21(6):4683-4715. PubMed ID: 36156387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size and molecular flexibility of sugars determine the storage stability of freeze-dried proteins.
    Tonnis WF; Mensink MA; de Jager A; van der Voort Maarschalk K; Frijlink HW; Hinrichs WL
    Mol Pharm; 2015 Mar; 12(3):684-94. PubMed ID: 25581526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation development of frozen parenteral dosage forms.
    Chilamkurti RN
    J Parenter Sci Technol; 1992; 46(4):124-9. PubMed ID: 1453281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrolyte-induced changes in glass transition temperatures of freeze-concentrated solutes.
    Her LM; Deras M; Nail SL
    Pharm Res; 1995 May; 12(5):768-72. PubMed ID: 7479566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexes.
    Hinrichs WL; Sanders NN; De Smedt SC; Demeester J; Frijlink HW
    J Control Release; 2005 Mar; 103(2):465-79. PubMed ID: 15763627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions.
    Wiesholzer M; Winter A; Kussmann M; Zeitlinger M; Pichler P; Burgmann H; Reznicek G; Poeppl W
    Perit Dial Int; 2017 1-2; 37(1):51-55. PubMed ID: 27605684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes.
    Kasper JC; Troiber C; Küchler S; Wagner E; Friess W
    Eur J Pharm Biopharm; 2013 Oct; 85(2):294-305. PubMed ID: 23747745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-guest inclusion system of mangiferin with β-cyclodextrin and its derivatives.
    Yang X; Zhao Y; Chen Y; Liao X; Gao C; Xiao D; Qin Q; Yi D; Yang B
    Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):2386-91. PubMed ID: 23498273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.